Skip to content

Electroacupuncture for Preventing Postoperative Delirium in Older Adults Undergoing Total Knee Arthroplasty

Electroacupuncture for Preventing Postoperative Delirium in Older Adults Undergoing Total Knee Arthroplasty: a Multicentre Randomised Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06564506
Enrollment
1460
Registered
2024-08-21
Start date
2025-11-10
Completion date
2026-08-30
Last updated
2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Keywords

Older adults, Electroacupuncture, Postoperative delirium, Total knee arthroplasty

Brief summary

Electroacupuncture may improve cognitive function and altered consciousness, but its effect on postoperative delirium in older arthroplasty patients remains unexplored. This study aims to assess the efficacy of electroacupuncture in preventing postoperative delirium in older adults undergoing total knee arthroplasty.

Detailed description

Electroacupuncture combines traditional acupuncture with electrical stimulation at specific body points. Recent clinical studies have shown promising results for acupuncture-related techniques in managing perioperative neurocognitive disorders. However, the efficacy of electroacupuncture in preventing postoperative delirium in elderly patients undergoing total knee arthroplasty remains unexplored.This randomised controlled trial aims to evaluate the efficacy of electroacupuncture in preventing postoperative delirium in elderly patients undergoing total knee arthroplasty.

Interventions

DEVICEDisposable acupuncture needles (0.30 × 75 mm)

Disposable acupuncture needles (0.30 × 75 mm), placebo needles (0.30 × 25 mm) and SDZ-V electroacupuncture devices (Hwato, Suzhou Medical Supplies Factory Co Ltd, China) will be used. Electrodes attached to the needle handles will deliver stimulation for 30 minutes (2 Hz/15 Hz frequency, 1 mA intensity) to cause mild skin movement without pain.

DEVICEPlacebo needles (0.30 × 25 mm)

Disposable acupuncture needles (0.30 × 75 mm), placebo needles (0.30 × 25 mm) and SDZ-V electroacupuncture devices (Hwato, Suzhou Medical Supplies Factory Co Ltd, China) will be used. Sham electroacupuncture will use blunt-tipped placebo needles without current output, which retract into their handles to simulate skin insertion.

DEVICESDZ-V electroacupuncture devices

Disposable acupuncture needles (0.30 × 75 mm), placebo needles (0.30 × 25 mm) and SDZ-V electroacupuncture devices (Hwato, Suzhou Medical Supplies Factory Co Ltd, China) will be used. Electrodes attached to the needle handles will deliver stimulation for 30 minutes (2 Hz/15 Hz frequency, 1 mA intensity) to cause mild skin movement without pain.

Sponsors

Fujian Provincial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Aged 65-90 years * American Society of Anaesthesiologists (ASA) physical status class II or III * Scheduled for elective unilateral total knee arthroplasty under general anesthesia

Exclusion criteria

* Baseline dementia or Mini-Mental State Examination (MMSE) score below 24 * Implanted electrical devices (eg, pacemakers, brain or spinal cord neurostimulator) * Infection or abscess at any selected acupuncture point * Severe hematopoietic or hemorrhagic disease * Severe audio-visual impairments or inability to communicate in Mandarin * Alcohol or illicit drug misuse disorder * Current use of sedatives, antidepressants or glucocorticoids * Received acupuncture or electroacupuncture within one month before surgery * Any condition deemed unsafe or unsuitable by the research team

Design outcomes

Primary

MeasureTime frameDescription
The incidence of postoperative delirium within the first three postoperative daysAt least two hours postsurgery and twice daily (09:00-11:00 and 18:00-20:00) for three daysThe incidence of POD within the first three postoperative days will be assessed using the Confusion Assessment Method (CAM). The CAM evaluates four diagnostic features: (1) acute onset or fluctuating course, (2) inattention, (3) disorganised thinking and (4) altered consciousness. Delirium is diagnosed when features 1 and 2 are present, with either 3 or 4. Blinded investigators will assess for POD at least two hours postsurgery and twice daily (09:00-11:00 and 18:00-20:00) for three days.

Secondary

MeasureTime frameDescription
Delirium subtypesAt least two hours postsurgery and twice daily (09:00-11:00 and 18:00-20:00) for three daysRichmond Agitation Sedation Scale (RASS); hypoactive (-3 to 0), hyperactive (+1 to +4) or mixed
Cognitive functionAt 1, 3, 6 and 12 months postoperativelyAbbreviated Mental Test Score (AMTS) via telephone at 1, 3, 6 and 12 months postoperatively
Anxiety and depressionAssessed preoperatively and daily for three days postoperativelyHospital Anxiety and Depression Scale (HADS); 14-item checklist (7 for anxiety, 7 for depression); each item scored 0-3; total score \>8 suggests mild disorder, \>10 moderate disorder
Postoperative painAssessed at 1, 3, 6, 12, 24, 36, 48, 60 and 72 hours postsurgery11-point Numerical Rating Scale (0 = no pain, 10 = worst pain imaginable) at rest and movement
Delirium severityAt least two hours postsurgery and twice daily (09:00-11:00 and 18:00-20:00) for three daysDelirium Rating Scale-Revised-98 (DRS-R-98); range 0-39, higher scores indicate greater severity
Recovery qualityAssessed daily for three days postoperativelyChinese version of the 15-item Quality of Recovery Questionnaire (QoR-15); range 0-150, higher scores indicate better recovery
Sleep qualityAssessed preoperatively and daily for three days postoperativelyRichards-Campbell Sleep Questionnaire (RCSQ); higher mean scores indicate better sleep
Adverse eventsthrough study completion, an average of 7 daysAny adverse events during the study will be documented on the electronic medical records
Postoperative morphine consumptionDuring 72 hours postsurgeryCumulative morphine use and rescue analgesia recorded over 72 hours postsurgery

Countries

China

Contacts

Primary ContactYusheng Yao, MD
fjslyys@126.com+86-13559939629

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026